HealthcareServices

Lung Cancer Surgery Market 2026–2030: Forecast, Innovation, and Competitive Trends

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the lung cancer surgery market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Lung Cancer Surgery Market expected to grow between 2026 and 2030?

The lung cancer surgery market size has demonstrated robust growth in recent years. It is forecast to expand from $5.33 billion in 2025 to $5.6 billion in 2026, registering a compound annual growth rate (CAGR) of 5.1%. The increase observed in the past can be attributed to a rise in lung cancer incidence rates, the enhancement of hospital surgical capabilities, the presence of trained thoracic surgeons, the increasing acceptance of video-assisted thoracoscopic surgery, and greater awareness of early-stage lung cancer treatment.

The lung cancer surgery market size is anticipated to experience consistent growth over the coming years, with expectations to reach $6.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is fueled by elements such as the increasing integration of robotic surgery platforms, a heightened demand for precise surgical results, the expansion of specialized cancer care centers, growing investments in surgical technology, and the wider adoption of enhanced recovery after surgery protocols. Furthermore, significant trends foreseen in this period include the rising adoption of minimally invasive surgical techniques, an increase in the utilization of robotic-assisted thoracic surgery, a growing inclination towards lung-preserving procedures, the broadening use of advanced surgical instruments, and an amplified focus on post-surgical recovery outcomes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25816&type=smp

Which Drivers Are Influencing Market Acceleration In The Lung Cancer Surgery Market?

The increasing occurrence of lung cancer is anticipated to stimulate the growth of the lung cancer surgery market in the future. Lung cancer involves the uncontrolled proliferation of abnormal cells in one or both lungs, which can disrupt normal lung function. The escalating incidence of lung cancer results from prolonged exposure to air pollution, particularly particulate matter, as these minute particles can penetrate deep into the lungs, leading to inflammation, cellular damage, and genetic mutations that contribute to cancer development. Lung cancer surgery aids in lowering the number of lung cancer-related deaths by enabling the early excision of malignant tumors before they have a chance to spread or advance. For example, in June 2025, information from the Centers for Disease Control and Prevention, a US-based federal government agency, revealed that in 2023, lung cancer was responsible for 131,584 deaths in the United States, after 218,893 newly reported cases in 2022. Thus, the rising incidence of lung cancer is fueling the expansion of the lung cancer surgery market.

What Leading Segments Are Studied In The Lung Cancer Surgery Market?

The lung cancer surgery market covered in this report is segmented –

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries

2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction

3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments

4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels

5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users

Subsegments:

1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection

2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Trends Are Driving The Growth Trajectory Of The Lung Cancer Surgery Market?

Leading companies within the lung cancer surgery market are concentrating on developing innovative technologies, such as robotic-assisted surgeries, to enhance surgical precision, reduce recovery time, and improve patient outcomes. Robotic-assisted surgeries involve minimally invasive procedures carried out using robotic systems controlled by surgeons, designed to boost accuracy, decrease complications, and improve patient recovery. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform provides enhanced reach and stability to access small, difficult-to-reach lung nodules, thereby improving the ability to diagnose lung cancer at earlier stages. Its advanced maneuverability and integration with imaging technologies facilitate more accurate biopsies while minimizing patient discomfort. Designed to expand procedural capabilities and streamline workflow, the platform supports greater clinical confidence and consistency across a broader range of bronchoscopic procedures.

Which Key Market Players Are Investing In Expansion And Innovation Within The Lung Cancer Surgery Market?

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/lung-cancer-surgery-global-market-report

Which Regions Are Projected To Dominate The Lung Cancer Surgery Market In The Coming Years?

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Lung Cancer Surgery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25816&type=smp

Browse Through More Reports Similar to the Global Lung Cancer Surgery Market 2026, By The Business Research Company

Non Small Cell Lung Cancer Nsclc Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Lung Cancer Diagnostic And Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Non Small Cell Lung Cancer Nsclc Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-small-cell-lung-cancer-nsclc-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795